The authors concluded that there is a low risk of the development of clinically significant hypothyroidism in initially euthyroid GH-deficient children during growth promoting therapy and L-thyroxine supplementation is seldom necessary [11]. The gene discussed is GH1; the disease is hypothyroidism.